SLC19A2 Gene Thiamine-Responsive Megaloblastic Anemia Syndrome Genetic Test sale cost 4400 AED
CSF3R Gene Neutrophilia Hereditary Genetic Test sale cost 4400 AED CSF3R Gene Neutrophilia Hereditary Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive Genetic Test sale cost 4400 AED IGHM Gene Agammaglobulinemia Type 1 Autosomal Recessive Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

SLC19A2 Gene Thiamine-Responsive Megaloblastic Anemia Syndrome Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The SLC19A2 gene plays a crucial role in the body’s thiamine (vitamin B1) transport, and mutations in this gene can lead to Thiamine-Responsive Megaloblastic Anemia Syndrome (TRMA), also known as Rogers Syndrome. This rare, autosomal recessive disorder is characterized by a triad of megaloblastic anemia, diabetes mellitus, and sensorineural deafness. Early diagnosis and treatment with thiamine can significantly improve symptoms and prevent complications.

To diagnose this condition, a genetic test targeting the SLC19A2 gene can be performed. DNA Labs UAE offers this specific test, providing a comprehensive analysis to identify mutations associated with TRMA. The test cost is 4400 AED and involves collecting a DNA sample, usually through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of mutations in the SLC19A2 gene.

This genetic test is a critical tool for confirming the diagnosis of Thiamine-Responsive Megaloblastic Anemia Syndrome, allowing for timely and appropriate management of the condition. It is particularly valuable for families with a history of TRMA, as it can aid in early detection and treatment of affected family members, significantly improving their quality of life.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome Genetic Test

Are you concerned about Thiamine-responsive megaloblastic anemia syndrome? DNA Labs UAE offers the SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome Genetic Test to help diagnose this rare autosomal recessive disorder.

Test Details

The SLC19A2 gene is associated with Thiamine-responsive megaloblastic anemia syndrome (TRMA). TRMA is characterized by megaloblastic anemia, diabetes mellitus, and sensorineural deafness. Our NGS (Next-Generation Sequencing) genetic testing method allows for the simultaneous analysis of multiple genes, including the SLC19A2 gene, to identify mutations or variants that may be responsible for the syndrome.

Test Components and Price

  • Test Name: SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome Genetic Test
  • Price: 4400.0 AED

Sample Condition

We accept blood samples, extracted DNA, or one drop of blood on an FTA card for this test.

Report Delivery

Reports are typically delivered within 3 to 4 weeks.

Method

We use NGS (Next-Generation Sequencing) technology for this genetic test.

Test Type

This test falls under the category of Hematology.

Doctor and Test Department

This test is conducted by a Hematologist and falls under the Genetics department.

Pre Test Information

Prior to the test, it is recommended to provide the clinical history of the patient who is undergoing the SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome NGS Genetic DNA Test. A Genetic Counselling session will also be conducted to draw a pedigree chart of family members affected by the syndrome.

About Thiamine-responsive megaloblastic anemia syndrome

Thiamine-responsive megaloblastic anemia syndrome (TRMA) is a rare autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus, and sensorineural deafness. Individuals with TRMA may experience a range of symptoms, including fatigue, pale skin, enlarged red blood cells, increased thirst and urination, and hearing loss.

NGS Genetic Testing

NGS genetic testing is a powerful tool that allows for the rapid and accurate sequencing of large amounts of DNA. It can be used to identify mutations or variants in the SLC19A2 gene that may be responsible for Thiamine-responsive megaloblastic anemia syndrome. By analyzing the SLC19A2 gene using NGS, clinicians can provide an accurate diagnosis, genetic counseling, and potentially targeted treatment options for individuals with the syndrome.

Don’t let Thiamine-responsive megaloblastic anemia syndrome go undiagnosed. Contact DNA Labs UAE today to schedule your SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome Genetic Test.

Test Name SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Hematology
Doctor Hematologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC19A2 Gene Thiamine-responsive megaloblastic anemia syndrome NGS Genetic DNA Test gene SLC19A2
Test Details

The SLC19A2 gene is associated with Thiamine-responsive megaloblastic anemia syndrome (TRMA). TRMA is a rare autosomal recessive disorder characterized by megaloblastic anemia, diabetes mellitus, and sensorineural deafness.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or even the entire genome. It uses high-throughput sequencing technologies to rapidly and accurately sequence large amounts of DNA. NGS genetic testing can be used to identify mutations or variants in the SLC19A2 gene that may be responsible for Thiamine-responsive megaloblastic anemia syndrome.

By analyzing the SLC19A2 gene using NGS, clinicians can identify specific mutations or variants that may be causing the disorder. This information can be used for accurate diagnosis, genetic counseling, and potentially targeted treatment options for individuals with Thiamine-responsive megaloblastic anemia syndrome.

SKU: TEST-3952 Category:

Related products